Diabetic retinopathy screening with confocal fundus camera and artificial intelligence - assisted grading.

Journal: European journal of ophthalmology
Published Date:

Abstract

PURPOSE: Screening for diabetic retinopathy (DR) by ophthalmologists is costly and labour-intensive. Artificial Intelligence (AI) for automated DR detection could be a clinically and economically alternative. We assessed the performance of a confocal fundus imaging system (DRSplus, Centervue SpA), coupled with an AI algorithm (RetCAD, Thirona B.V.) in a real-world setting.

Authors

  • A Piatti
    Eye-Unit, Primary Care, ASL TO5, Regione Piemonte, Italy.
  • C Rui
    Centervue SpA, Padova, Italy.
  • S Gazzina
    Centervue SpA, Padova, Italy.
  • B Tartaglino
    Chaira Medica Association, Chieri, Italy.
  • F Romeo
    Metabolism and Diabetes Unit, ASLTO 5, Regione Piemonte, Italy.
  • R Manti
    Metabolism and Diabetes Unit, ASLTO 5, Regione Piemonte, Italy.
  • M Doglio
    Metabolism and Diabetes Unit, ASLTO 5, Regione Piemonte, Italy.
  • E Nada
    Metabolism and Diabetes Unit, ASLTO 5, Regione Piemonte, Italy.
  • C B Giorda
    Metabolism and Diabetes Unit, ASLTO 5, Regione Piemonte, Italy.